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ABSTRACT
Objective: To determine whether vitamin C
administration influences exercise-induced
bronchoconstriction (EIB).
Design: Systematic review and meta-analysis.
Methods: MEDLINE and Scopus were searched for
placebo-controlled trials on vitamin C and EIB. The
primary measures of vitamin C effect used in this study
were: (1) the arithmetic difference and (2) the relative
effect in the postexercise forced expiratory volume in
1 s (FEV1) decline between the vitamin C and placebo
periods. The relative effect of vitamin C administration
on FEV1 was analysed by using linear modelling for
two studies that reported full or partial individual-level
data. The arithmetic differences and the relative effects
were pooled by the inverse variance method. A
secondary measure of the vitamin C effect was the
difference in the proportion of participants suffering
from EIB on the vitamin C and placebo days.
Results: 3 placebo-controlled trials that studied the
effect of vitamin C on EIB were identified. In all, they
had 40 participants. The pooled effect estimate
indicated a reduction of 8.4 percentage points (95% CI
4.6 to 12) in the postexercise FEV1 decline when
vitamin C was administered before exercise. The
pooled relative effect estimate indicated a 48%
reduction (95% CI 33% to 64%) in the postexercise
FEV1 decline when vitamin C was administered before
exercise. One study needed imputations to include it in
the meta-analyses, but it also reported that vitamin C
decreased the proportion of participants who suffered
from EIB by 50 percentage points (95% CI 23 to 68);
this comparison did not need data imputations.
Conclusions: Given the safety and low cost of vitamin
C, and the positive findings for vitamin C
administration in the three EIB studies, it seems
reasonable for physically active people to test vitamin C
when they have respiratory symptoms such as cough
associated with exercise. Further research on the
effects of vitamin C on EIB is warranted.
INTRODUCTION
Exercise-induced bronchoconstriction (EIB)
is a transient narrowing of the airways that
occurs during or after exercise. Usually, a
10% or greater exercise-induced decline in
forced expiratory volume in 1 s (FEV1) is clas-
siﬁed as EIB.1 The prevalence of EIB varies
from about 10% in the general population to
about 50% in some ﬁelds of competitive ath-
letics.1 The pathophysiology of EIB is not well
understood. However, respiratory water loss
leads to the release of inﬂammatory media-
tors, such as histamine, leukotrienes (LTs)
and prostaglandins (PGs), all of which can
cause bronchoconstriction.1 2 Increased levels
of exhaled nitric oxide have also been asso-
ciated with EIB.3
There is evidence that vitamin C plays a
role in lung function. The production of
various prostanoids in lung tissues is inﬂu-
enced by vitamin C, and vitamin C deﬁciency
increases the level of bronchoconstrictor
PGF2α.
4–6 An increase in airway hyper-
responsiveness to histamine, which was
further enhanced by indomethacin adminis-
tration, was observed in guinea pigs on a diet
deﬁcient in vitamin C.6 In isolated guinea
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pig trachea smooth muscle, vitamin C decreased the
contractions caused by PGF2α, histamine and carbamyl-
choline.4 7 8 Indomethacin antagonised the effect of
vitamin C on chemically induced bronchoconstriction in
humans9 10 and the effect of vitamin C on the contrac-
tions of guinea pig tracheal muscle.8 Thus, the effects of
vitamin C might be partly mediated by alterations in PG
metabolism. In humans, a 2-week vitamin C (1.5 g/day)
administration regime reduced the postexercise increase
in the urinary markers for the bronchoconstrictors
LTC4–LTE4 and PGD2, in addition to reducing the
increase in exhaled nitric oxide.11
Heavy physical exertion generates oxidative stress, and
therefore, as an antioxidant, the effects of vitamin C
might be more manifest in people doing exercise.12 13
The importance of vitamin C on the respiratory system is
also indicated by the decrease in the incidence of the
common cold in people under heavy acute physical
stress14 15 and by its effects on the severity of the upper
and lower respiratory tract infections.15–17
Previously, a systematic review examined the effect of
vitamin C on EIB.18 However, there were substantial
errors in the extraction of data and data analysis in that
review.19 The purpose of this systematic review is to
examine whether vitamin C administration inﬂuences
the postexercise FEV1 decline.
METHODS
Types of studies
Controlled trials, both randomised and non-randomised,
were included in this systematic review. Only placebo-
controlled blinded trials were included as the severity of
EIB might be affected by the patients’ awareness of the
treatment. Studies that used children and adults of
either gender and any age were considered eligible.
Types of interventions
The intervention considered was oral or intravenous
administration of vitamin C (ascorbic acid or its salts) of
at least 0.2 g daily for a single day or for a more
extended period. The dose limit was set as a pragmatic
choice. When a trial with a low dose gives a negative
result, the negative ﬁndings can be attributed to that low
dosage. Thus, trials with large doses are more critical for
testing whether vitamin C is effective in inﬂuencing EIB.
The outcomes and the measure of the vitamin C effect
The primary outcome in this meta-analysis is the relative
FEV1 decline caused by exercise (as a percentage). The
measures selected for the vitamin C effect were: (1) the
arithmetic difference in the postexercise decline of FEV1
between the placebo and vitamin C periods; this is
called the percentage point difference and (2) the rela-
tive effect in the decline of postexercise FEV1 between
the vitamin C and placebo periods. A secondary
outcome in this meta-analysis was the proportion of par-
ticipants who suffered from EIB after the exercise test,
and the measure of vitamin C effect was taken as the dif-
ference in the occurrence in EIB between the vitamin C
and placebo days.
Literature searches
MEDLINE (OVID) was searched using the Medical
Subject Headings (MeSH) terms ‘ascorbic acid’ and
‘exercise-induced asthma’. A similar search was carried
out in Scopus. No language restrictions were used. The
databases were searched from their inception to
February 2013. The reference lists of identiﬁed studies
and review articles were screened for additional refer-
ences. See online supplementary ﬁle 1 for the ﬂow
diagram of the literature search.
Selection of studies and data extraction
Five controlled trials that report on vitamin C and EIB
were identiﬁed. Three of them satisﬁed the selection cri-
teria (table 1). One of the studies that was not included
was not placebo controlled22 and the other studied the
combination of vitamins C and E.23 The data of the
three included trials were extracted and analysed. The
original study authors were contacted when appropriate
in order to obtain further data.
Schachter and Schlesinger20 reported the individual-level
FEV1 measurements for a 12-participant crossover study.
The decline in FEV1 caused by exercise was calculated in
this present study (see online supplementary ﬁle 2).
Tecklenburg et al11 reported the mean decline in post-
exercise FEV1 for the vitamin C and placebo phases of
an eight-participant crossover study. However, these
authors did not report the paired SD value for the mean
difference between the two phases. Dr Tecklenburg was
subsequently contacted, and she kindly sent the paired
SD value for the mean difference in decline of the post-
exercise FEV1 (see online supplementary ﬁle 2).
Cohen et al21 reported FEV1 values before and after
exercise in only 11 of the 20 participants of a crossover
study. These 11 had been selected because of the dis-
appearance of EIB during the study. Thus, the difference
in the postexercise FEV1 decline between the vitamin C
and placebo days can be calculated for these 11 partici-
pants (the mean vitamin C effect was a reduction of 20.4
percentage points in the postexercise decline in FEV1).
Dr Cohen was contacted, but he no longer retained those
data. Therefore, to include the Cohen et al trial in this
meta-analysis, the FEV1 values for the remaining nine
participants had to be imputed. A conservative ‘no
vitamin C effect’ estimate was imputed for all the nine
participants with missing data (see online supplementary
ﬁle 2). As a sensitivity analysis, the Cohen et al study was
excluded from the meta-analysis in ﬁgure 1 to examine
whether its exclusion inﬂuenced the conclusions.
Cohen et al also reported the number of participants
who suffered from EIB after the exercise test. This
outcome did not require imputations and it was used as
a secondary outcome for comparing the vitamin C and
placebo days in the Cohen study.
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Statistical analysis
The statistical heterogeneity of the three studies was
assessed by using the χ2 test and the I2 index.24 The
latter examines the percentage of total variation across
studies that is due to heterogeneity between studies
rather than by randomness. A value of I2 greater than
Table 1 Trials on vitamin C supplementation and exercise-induced bronchoconstriction
Study Descriptions
Schachter and Schlesinger20 Methods Randomised, double-blind, placebo-controlled crossover trial
Participants 12 asthmatic participants, selected from among workers of Yale University in
the USA: “all 12 participants gave a characteristic description of EIB.” All
included participants had at least 20% reduction in maximal expiratory flow
40% after exercise
5 Males, 7 females; mean age of 26 years (SD 5 years)
Type of
exercise
Exercise by using a cycloergometer was begun at a constant speed of 20 km/
h against a zero workload. At the end of each 1 min interval, the workload
was increased by 150 kpm/min, keeping the pedalling speed constant
throughout the experiment. Exercise against progressively larger workloads
was continued until either the heart rate reached 170 bpm or the participants
fatigued
Intervention On 2 subsequent days, the participants ingested 0.5 g of vitamin C or sucrose
placebo in identical capsules 1.5 h before the exercise. Washout overnight
Outcome Change in FEV1 was calculated as: (preexercise vs 5 min postexercise)
Notes See online supplementary file 2 for the calculation of the vitamin C effect from
the individual-level data
Cohen et al 21 Methods Randomised, double-blind, placebo-controlled crossover trial
Participants 20 asthmatic participants in Israel. All of them had demonstrated EIB by
having a ‘decline of at least 15%’ in FEV1 after a standard exercise test
13 Males, 7 females; mean age of 14 years (range 7–28 years)
Type of
exercise
A 7 min exercise session using a motorised treadmill. Each participant
exercised to submaximal effort at a speed and slope to provide 80% of the
motional oxygen consumption as adjudged by a pulse oximeter
Intervention 2 g of vitamin C or placebo 1 h before the exercise. Washout 1 week
Outcomes Change in FEV1 was calculated as: (preexercise vs 8 min postexercise).
Secondary outcome: proportion of participants who suffered from EIB after the
exercise session (decline in FEV1 at least 15%)
Notes Individual-level data on the FEV1 levels was reported only for 11 of the 20
participants (Cohen et al, table 2). Dr Cohen was contacted, but he no longer
had the data. Therefore, a conservative ‘no vitamin C effect’ was imputed for
the 9 participants for whom experimental data were not available; see online
supplementary file 2
Tecklenburg et al11 Methods Randomised, double-blind, placebo-controlled crossover trial
Participants 8 participants from a population of university students and the local
community, Indiana, USA, with physician-diagnosed mild-to-moderate asthma.
All participants had documented EIB as indicated by a ‘drop greater than
10%’ in postexercise FEV1. They also had a history of chest tightness,
shortness of breath and intermittent wheezing following exercise.
2 Males, 6 females; mean age of 24.5 years (SD 5 years)
Type of
exercise
Participants ran on a motorised treadmill, elevated by 1% per min until 85% of
the age-predicted maximum heart rate and ventilation exceeding 40–60% of
the predicted maximum voluntary ventilation. Participants maintained this
exercise intensity for 6 min. Following the 6 min steady state exercise, the
grade of the treadmill continued to increase at 1% per min until volitional
exhaustion
Intervention 1.5 g vitamin C or sucrose placebo was administered as capsules matched for
colour and size daily for 2 weeks. Washout 1 week.
Participants were advised to avoid high vitamin C foods during the study
Outcome Change in FEV1 was calculated as: (preexercise vs the lowest value within
30 min postexercise)
Notes Dr Tecklenburg kindly made the mean and SD for the paired FEV1 decline
available. For the decline in FEV1 level, the mean difference was +6.5
percentage points (paired SD 7.4) in favour or vitamin C
EIB, exercise-induced bronchoconstriction; FEV1, forced expiratory volume in 1 s.
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about 70% indicates a high level of heterogeneity. Since
the three identiﬁed trials showed no statistical hetero-
geneity, their results were pooled using the inverse vari-
ance method assuming a ﬁxed effect by running the
program ‘metagen’ of the R package (see online supple-
mentary ﬁle 2 for details of the calculations).25 The
program ‘forest.meta’ of the R package was used to con-
struct the forest plots.
To examine the relative effect of vitamin C on the post-
exercise FEV1 decline, the vitamin C effect was modelled
using the placebo-day postexercise FEV1 decline as the
explanatory variable, by using the linear model “lm”
program of the R package.25 To test whether the addition
of the placebo-day postexercise FEV1 decline values signiﬁ-
cantly improves the linear model ﬁt, the model containing
the placebo-day FEV1 decline values was compared with
the model without them. The improvement of the model
ﬁt was calculated from the change in −2×log (likelihood),
which follows the χ2 (1 df) distribution.
To study the effect of vitamin C on the proportion of
participants who suffered from EIB in the Cohen et al
study, the mid p value was calculated26 and the 95% CI
was calculated by using the Agresti-Caffo method.27
The two-tailed p values are presented in this text.
RESULTS
Three randomised, placebo-controlled, double-blind cross-
over trials that had examined the effect of vitamin C sup-
plementation on the decline in FEV1 caused by exercise
were retrieved. Double-blind means that all studies used
allocation concealment, although the term was not used.
The experimental conditions were similar (table 1). The
three trials had a total of 40 participants. There was no stat-
istical heterogeneity found between the three studies for
the percentage points scale: I2=0%; χ2 (2 df)=1.1; p=0.5.
Therefore, the pooled percentage point estimate of the
vitamin C effect was calculated (ﬁgure 1). Compared with
the placebo phases, the mean reduction in the postexer-
cise FEV1 decline was 8.4 percentage points during the
vitamin C phases (95% CI 4.6 to 12.2; p<0.001).
In the Schachter and Schlesinger20 study, the postexer-
cise FEV1 decline was 17.6% for placebo, but only 10.2%
for vitamin C (0.5 g single dose), with a 7.4 percentage
point (95% CI −0.1 to 14.9; p=0.054) improvement for
the vitamin C treatment. In the Tecklenburg et al11
study, the postexercise FEV1 decline was 12.9% when on
placebo, but only 6.4% when on vitamin C (1.5 g/day
for 2 weeks), indicating an improvement of 6.5 percent-
age points (95% CI 0.3 to 12.7; p=0.042) for vitamin C.
With the conservative imputation of the ‘no vitamin C
effect’ for nine participants in the Cohen et al21 study,
there was a reduction in the postexercise FEV1 decline
by 11.2 percentage points (95% CI 4.8 to 17.6; p=0.002)
on the vitamin C day (2 g single dose).
EIB is not a dichotomous condition; instead, there is a
continuous variation in the possible level of FEV1
decline caused by exercise. A single constant percentage
point estimate of the vitamin C effect for all people who
suffer from EIB may thus be simplistic. Instead, it is pos-
sible that a relative scale would better capture the effect
of vitamin C. Schachter and Schlesinger20 published
individual-level data for all their 12 participants, and
thus their data were analysed using linear modelling to
examine whether the vitamin C effect might depend on
the placebo-day postexercise FEV1 decline, that is, on
the baseline severity of EIB (ﬁgure 2). Adding the
placebo-day postexercise FEV1 decline values to the null
linear model, which is equivalent to the t test, improved
the model ﬁt by χ2 (1 df)=16.5, corresponding to
p<0.001. This indicates that the linear model that
includes the placebo-day postexercise FEV1 decline
explains the effect of vitamin C much better than the
constant 7.4 percentage point effect for all their partici-
pants suffering from EIB. The slope of the linear model
indicates a 55% reduction in the decline of the postexer-
cise FEV1 (95% CI 32% to 78%; p<0.001) for vitamin C
administration compared with placebo. Thus, in the per-
centage points scale, though there was a trend towards a
mean vitamin C effect, the difference between vitamin C
and placebo in the Schachter and Schlesinger trial was
not signiﬁcant (p=0.054), whereas in the linear model
Figure 1 Percentage point effect of vitamin C on the decline in FEV1 caused by exercise. The horizontal lines indicate the 95%
CI for the three trials and the squares in the middle of the lines indicate the mean effect of the study. The diamond shape at the
bottom indicates the 95% CI for the pooled effect. FEV1, forced expiratory volume in 1 s; seTE, SE of TE; TE, treatment effect;
W, weight of the study.
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the slope indicates a highly signiﬁcant difference
between vitamin C and placebo (p<0.001).
Cohen et al21 published individual-level data for only
11 of their 20 participants (ﬁlled squares in ﬁgure 3).
A conservative ‘no vitamin C effect’ was imputed for the
remaining nine participants (open squares in ﬁgure 3).
Only those participants who had a decline in postexer-
cise FEV1 of at least 15% were included in the Cohen
et al study, and therefore the horizontal variation in the
Cohen et al data was narrow. Fitting the linear regression
line through the origin indicates a 42% reduction in the
postexercise FEV1 decline (95% CI 19% to 64%) with
vitamin C administration.
Tecklenburg et al11 did not report individual-level data
for their eight participants and the data were not avail-
able. The mean values indicate a 50.4% (95% CI 2.4%
to 98%) reduction in the postexercise FEV1 decline for
the vitamin C period.
There was no statistical heterogeneity found between
the three studies on the relative effect scale: I2=0%; χ2
(2 df)=0.7; p=0.7. Therefore, the pooled estimate of the
relative vitamin C effect was calculated for the three
trials (ﬁgure 4). Compared with the placebo phases,
vitamin C administration reduced the postexercise FEV1
decline by 48% (95% CI 33% to 64%; p<0.001).
As a sensitivity test, the Cohen et al study was excluded
from the meta-analysis in ﬁgure 1. On the basis of the
two remaining trials, the estimate of the vitamin C effect
on the postexercise FEV1 decline became 6.8 percentage
points (95% CI 2.0 to 11.6; p=0.005). Thus, the Cohen
et al study imputations are not crucial for the conclusion
that vitamin C inﬂuences the postexercise FEV1 decline.
Finally, although Cohen et al did not report individual-
level data for the postexercise FEV1 decline values for
nine of their participants, they reported the presence or
absence of EIB (at least a 15% decline in postexercise
FEV1) on the vitamin C and placebo days and this
dichotomised FEV1 outcome does not suffer from
missing data. On the placebo day, 100% (20/20) of par-
ticipants suffered from EIB, whereas on the vitamin C
day, only 50% (10/20) suffered from EIB. This outcome
gives a 50 percentage point decrease (95% CI 23 to 68;
p<0.001) in the occurrence of EIB following vitamin C
administration.
DISCUSSION
In this meta-analysis of three randomised placebo-
controlled double-blind trials, vitamin C was found to
reduce the postexercise decline in FEV1 by a mean of 8.4
percentage points (ﬁgure 1). Nevertheless, there is a
Figure 2 The effect of vitamin C on postexercise forced
expiratory volume in 1 s (FEV1) decline as a function of the
placebo-day postexercise FEV1 decline for the Schachter and
Schlesinger study.20 The squares show the 12 participants of
the study. The vertical axis shows the difference in
postexercise FEV1 decline between the vitamin C and the
placebo days. The horizontal axis shows the postexercise
FEV1 decline on the placebo day. The black line indicates the
fitted linear regression line. The horizontal dash (-) line
indicates the level of identity between vitamin C and placebo.
See online supplementary file 2 for the calculations.
Figure 3 The effect of vitamin C on postexercise forced
expiratory volume in 1 s (FEV1) decline as a function of the
placebo-day postexercise FEV1 decline for the Cohen et al
21
study. The filled squares show the 11 participants for whom
data were reported and the empty squares show the nine
participants for whom the conservative ‘no vitamin C effect’
data were imputed. The vertical axis shows the difference in
the postexercise FEV1 decline between the vitamin C and the
placebo days. The horizontal axis shows the postexercise
FEV1 decline on the placebo day. The black line indicates the
fitted linear regression line. The horizontal dash (-) line
indicates the level of identity between vitamin C and placebo.
The linear regression line was fitted through the origin, since
the variation in the placebo-day FEV1 decline values is
narrow. See online supplementary file 2 for the calculations.
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great variation in the level of FEV1 decline caused by
exercise. Therefore, it may not be reasonable to assume
that a single and constant percentage point estimate of
the vitamin C effect is valid for all persons suffering from
EIB. Linear modelling of the Schachter and
Schlesinger20 data indicated that it is much better to
study the response to vitamin C administration as a rela-
tive effect (ﬁgure 2). However, full individual-level data
were not available for the other two trials. Nonetheless,
all three studies are consistent with vitamin C administra-
tion halving the postexercise decline in FEV1 (ﬁgure 4).
The Cohen et al21 study required imputations for nine
participants; however, excluding the Cohen et al study
from the percentage point meta-analysis did not inﬂu-
ence conclusions. Furthermore, Cohen et al reported
that the number of participants who suffered from EIB
dropped from 100% on the placebo day to 50% on the
vitamin C day and this outcome did not require imputa-
tions; yet the highly signiﬁcant beneﬁt of vitamin C was
also seen in this outcome.
The three studies included in this systematic review
indicate that 0.5–2 g of vitamin C administration before
exercise may have a beneﬁcial effect on many people
suffering from EIB. All the three trials were double-blind
placebo-controlled randomised trials. The total number
of participants in the three trials is only 40. However, the
three trials were carried out in three different decades
and on two different continents. The criteria for EIB dif-
fered and the mean age of the participants was 14 years
in the Cohen et al study but 25 and 26 years in the two
other studies. Still, all the studies found a 50% reduction
in the postexercise FEV1 decline. It is not evident how
far this 50% estimate can be generalised, but the close
estimate in such different studies suggests that the esti-
mate may also be valid for several other people who
suffer from EIB.
The search, screening and selection for trials and data
extraction were carried out by one person, which may
be considered a limitation of this study. In addition, only
two databases were searched; however, in an independ-
ent literature search, the Cochrane review on vitamin C
and asthma did not identify more trials on vitamin C
and EIB.18 Data analysis was also performed by one
person, but the supplementary ﬁles show the extracted
data and data analyses, which makes the study transpar-
ent. No risk of bias or quality assessment was performed
as part of this study.
In evidence-based medicine, the primary question is
whether an intervention has effects on clinically relevant
outcomes, as well as on symptoms such as coughs. With
such a perspective, the aetiology of respiratory symptoms
is not of prime importance. Given the low cost and
safety of vitamin C,15 28 and the consistency of positive
ﬁndings in the three studies on EIB, it seems reasonable
for physically ﬁt and active people to test vitamin C on
an individual basis if they have respiratory symptoms
such as cough associated with exercise.
The promising results of EIB and common cold
studies indicate that further research on vitamin C and
the respiratory symptoms of physically active people are
warranted. In future trials, statistical modelling should
be used to examine the effect of vitamin C on FEV1
levels, instead of simply calculating the percentage point
estimates. Although the primary question in the
evidence-based medicine framework is to assess the
effectiveness of vitamin C on clinically relevant out-
comes, the aetiology of the respiratory symptoms should
also be investigated in future investigations.
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